Volume 60 • 1999 • Supplement 3

Publisher’s Podcast: An Audio Summary of This Issue

Listen to an audio summary of this issue

Subscribe to the Podcast

Outcome in Schizophrenia: Beyond Symptom Reduction

J Clin Psychiatry 1999;60(suppl 3):3-7

Methods of Cost-Effectiveness Analysis in the Evaluation of New Antipsychotics: Implications for Schizophrenia Treatment

J Clin Psychiatry 1999;60(suppl 3):9-14

Mental Health Care From the Public Perspective: The Texas Medication Algorithm Project

J Clin Psychiatry 1999;60(suppl 3):16-20

Cost-Utility Analysis in Schizophrenia

J Clin Psychiatry 1999;60(suppl 3):22-26

The Wisconsin Quality of Life Index: A Multidimensional Model for Measuring Quality of Life

J Clin Psychiatry 1999;60(suppl 3):29-31

Perspective and the Measurement of Costs and Benefits for Cost-Effectiveness Analysis in Schizophrenia

J Clin Psychiatry 1999;60(suppl 3):32-35

What About the Patient?

J Clin Psychiatry 1999;60(suppl 3):38-41

The Risperidone Outcomes Study of Effectiveness (ROSE): A Model for Evaluating Treatment Strategies in Typical Psychiatric Practice

J Clin Psychiatry 1999;60(suppl 3):42-47

Cost of Treating Mental Illness From a Managed Care Perspective

J Clin Psychiatry 1999;60(suppl 3):49-52

Panel on Cost-Effectiveness in Health and Medicine Recommendations: Identifying Costs

J Clin Psychiatry 1999;60(suppl 3):54-56

Concluding Discussion [Free]

J Clin Psychiatry 1999;60(suppl 3):59-60